Mt. Rademaker et al., COMPARISON OF CHRONIC NEUTRAL ENDOPEPTIDASE INHIBITION AND FUROSEMIDEIN AN OVINE MODEL OF HEART-FAILURE, Journal of cardiovascular pharmacology, 27(3), 1996, pp. 439-446
The hemodynamic, hormonal, and metabolic effects of chronic neutral en
dopeptidase (NEP) 24.11 inhibition and furosemide were compared in the
pacing model of ovine heart failure (HF). Intravenous SCH 39370 induc
ed a dose-related inhibition of NEP activity during 4-days treatment,
in association with a transient increase in plasma atrial natriuretic
peptide (ANP) and, at the higher dose, an increased mean level of plas
ma cyclic guanosine monophosphate. There was a significant and persist
ent decrease in left atrial pressure, a brief increase in cardiac outp
ut (GO), and a tendency for arterial pressure to be reduced. Significa
nt dose-related diuresis and natriuresis were also observed. Furosemid
e induced a similar hemodynamic response, associated with greater diur
esis and natriuresis. Both agents significantly reduced plasma aldoste
rone levels. Coinfusion of captopril on day 4 of treatment resulted in
similar responses in both the SCH 39370- and furosemide pretreated gr
oups. Chronic NEP inhibition significantly alters circulatory and rena
l function and appears to be as effective as furosemide in reducing ca
rdiac preload in this model of congestive HF.